Table 3.
Chronicity findings in LMN on rebiopsy
Case | Glomeruli/Sclerosed | IFTA, % | Follow-Up, yr | Rebiopsy: Glomeruli/Sclerosed | Rebiopsy: IFTA, % |
---|---|---|---|---|---|
1 | 17/1 (5.9%) | 0 | 2 | 17/2 (11.8%) | 0 |
2 | 10/0 (0%) | 0 | 2 | 26/0 (0%) | 0 |
3 | 3/0 (0%) | 0 | 10 | 42/2 (4.8%) | 0 |
4 | 7/0 (0%) | 0 | 7 | 42/19 (45.2%) | 25 |
Cases 1–3 are EXT1/EXT2-positive LMN and case 4 is EXT1/EXT2-negative LMN.